Nicolas Penet
Nicolas has several years of experience in investment and research valorisation, particularly at INSAVALOR. His role as President of Pertinence Invest gives him a pragmatic vision of the first stages of financing the deeptech projects that M2care is looking for. Nicolas graduated from CPE Lyon, the University of Strasbourg and EMLyon. Passionate about technology transfer, […]
Florence THUEUX
Florence has a dual experience as an entrepreneur and an investor in the healthcare sector. She has participated in the start-up, development and sell out of several companies, in positions of CFO then CEO and President, in roles of growth structuring, negotiation of deals, architecture of business’ and equity’s partnerships, M&A, strategy and management (Arrow […]
Célia HART
Celia has more than 15 years of private equity experience and has been at Supernova Invest since 2005 in charge of the early-stage team, the healthcare sector and the Supernova 2 fund. Prior to that, she held several senior positions at Cambridge Antibody Technology (Medimmune since its acquisition by Astra Zeneca), one of the UK’s […]
Philippe ARCHINARD
Philippe is Executive Vice President, Technological Innovation and Scientific Partnerships at Institut Mérieux since 2021.He was previously Chairman and Chief Executive Officer of Transgene from 2010 to 2020 and Chief Operating Officer from 2004 to 2020. Prior to joining Transgene, Philippe Archinard was Chief Executive Officer of Innogenetics since 2000. From 1985 to 2000, he […]
